Iridex (IRIX) Enterprise Value Growth (1y) (2011 - 2026)
Iridex (IRIX) Enterprise Value Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Iridex | 15.93 Mn | 11.33 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 36.57% |
| Jan 3, 2026 | -152.53% |
| Sep 27, 2025 | -44.38% |
| Jun 28, 2025 | -64.87% |
| Mar 29, 2025 | -33.68% |
| Dec 28, 2024 | 66.06% |
| Sep 28, 2024 | 51.64% |
| Jun 29, 2024 | 58.14% |
| Mar 30, 2024 | 50.95% |
| Dec 30, 2023 | 49.48% |
| Sep 30, 2023 | 49.67% |
| Jul 1, 2023 | 45.34% |
| Apr 1, 2023 | 46.42% |
| Dec 31, 2022 | 41.63% |
| Oct 1, 2022 | 37.98% |
| Jul 2, 2022 | 31.58% |
| Apr 2, 2022 | 26.34% |
| Jan 1, 2022 | -105.16% |
| Oct 2, 2021 | -114.28% |
| Apr 3, 2021 | -151.31% |